Aclarion (ACONW) Competitors $0.03 -0.01 (-14.63%) As of 05/22/2025 03:29 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock ACONW vs. AONC, DHACW, LFMDP, OTRKP, PIIIW, TALKW, TOIIW, NTRA, FMS, and HIMSShould you be buying Aclarion stock or one of its competitors? The main competitors of Aclarion include American Oncology Network (AONC), Digital Health Acquisition (DHACW), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), Oncology Institute (TOIIW), Natera (NTRA), Fresenius Medical Care (FMS), and Hims & Hers Health (HIMS). These companies are all part of the "healthcare" industry. Aclarion vs. American Oncology Network Digital Health Acquisition LifeMD Ontrak P3 Health Partners Talkspace Oncology Institute Natera Fresenius Medical Care Hims & Hers Health Aclarion (NASDAQ:ACONW) and American Oncology Network (NASDAQ:AONC) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, community ranking, earnings, profitability, institutional ownership, media sentiment, valuation and risk. Which has preferable earnings & valuation, ACONW or AONC? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAclarion$54.60KN/AN/AN/AN/AAmerican Oncology Network$1.34BN/AN/AN/AN/A Does the media favor ACONW or AONC? In the previous week, American Oncology Network's average media sentiment score of 0.68 beat Aclarion's score of 0.00 indicating that American Oncology Network is being referred to more favorably in the news media. Company Overall Sentiment Aclarion Neutral American Oncology Network Positive Does the MarketBeat Community prefer ACONW or AONC? Aclarion and American Oncology Network both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformAclarionN/AN/AAmerican Oncology NetworkN/AN/A Is ACONW or AONC more profitable? Company Net Margins Return on Equity Return on Assets AclarionN/A N/A N/A American Oncology Network N/A N/A N/A SummaryAmerican Oncology Network beats Aclarion on 2 of the 2 factors compared between the two stocks. Get Aclarion News Delivered to You Automatically Sign up to receive the latest news and ratings for ACONW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACONW vs. The Competition Export to ExcelMetricAclarionHealth Information Services IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$211.82M$5.33B$8.39BDividend YieldN/A6.68%5.21%4.10%P/E RatioN/A320.3626.7519.70Price / SalesN/A435.84392.41121.79Price / CashN/A47.1438.2534.62Price / BookN/A5.366.774.50Net IncomeN/A-$15.55M$3.23B$248.22M7 Day PerformanceN/A-0.02%0.43%-0.80%1 Month PerformanceN/A7.07%9.07%11.52%1 Year PerformanceN/A5.44%18.59%8.99% Aclarion Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACONWAclarionN/A$0.03-14.6%N/A+5.0%$0.00$54,601.000.007Positive NewsGap DownAONCAmerican Oncology NetworkN/A$6.00+2.6%N/A+211.2%$0.00$1.34B0.001,520Gap UpDHACWDigital Health AcquisitionN/A$0.04flatN/AN/A$0.00N/A0.00N/ALFMDPLifeMDN/A$24.40+1.7%N/A+16.6%$0.00$234.01M0.00230News CoverageOTRKPOntrakN/A$0.22-2.2%N/A-29.0%$0.00$10.84M0.00250Positive NewsGap DownPIIIWP3 Health PartnersN/A$0.01+31.8%N/AN/A$0.00$1.50B0.00500Gap DownTALKWTalkspaceN/A$0.14+27.5%N/A-35.8%$0.00$194.36M0.00500Gap DownHigh Trading VolumeTOIIWOncology InstituteN/A$0.07-1.4%N/A-39.9%$0.00$393.41M0.00660Gap DownNTRANatera3.2688 of 5 stars$152.28-3.2%$181.82+19.4%+40.5%$20.59B$1.83B-86.523,020Positive NewsFMSFresenius Medical Care3.1083 of 5 stars$27.99-0.4%$27.80-0.7%+40.5%$16.43B$19.49B23.13123,200News CoveragePositive NewsAnalyst ForecastHIMSHims & Hers Health2.3442 of 5 stars$64.02+16.0%$37.67-41.2%+231.1%$14.33B$1.78B145.50650Trending NewsAnalyst UpgradeGap DownHigh Trading Volume Related Companies and Tools Related Companies AONC Alternatives DHACW Alternatives LFMDP Alternatives OTRKP Alternatives PIIIW Alternatives TALKW Alternatives TOIIW Alternatives NTRA Alternatives FMS Alternatives HIMS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACONW) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aclarion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aclarion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
